Safety of Immune Checkpoint Inhibitors in Elderly Patients: An Observational Study

Safety of Immune Checkpoint Inhibitors in Elderly Patients: An Observational Study

Background: Immunotherapy has completely changed the treatment of solid tumors. Although immune checkpoint inhibitors (ICIs) seem to be an appealing alternative to chemotherapy, especially in elderly patients, due to a more tolerable toxicity profile, they can lead to a peculiar variety of immune-re...

Full description

Bibliographic Details
Main Authors: Agnese Paderi, Sara Fancelli, Enrico Caliman, Serena Pillozzi, Elisabetta Gambale, Marinella Micol Mela, Laura Doni, Francesca Mazzoni, Lorenzo Antonuzzo
Format: Article
Language:English
Published: MDPI AG 2021-08-01
Series:Current Oncology
Subjects:
aging
immunosenescence
ICI
elderly
skin toxicity
endocrinologic toxicity
Online Access:https://www.mdpi.com/1718-7729/28/5/283

Internet

https://www.mdpi.com/1718-7729/28/5/283

Similar Items